Form 4: Conduit Pharmaceuticals CEO Sells Shares
Insider Transaction (Form 4)
Andrew Regan, Chief Executive Officer and a Director of Conduit Pharmaceuticals Inc., sold 290 shares of common stock on July 30, 2026.
Summary
- Other acquisition/disposition: acquired 5,436,830 Common Stock on August 28, 2026; holds 5,693,223 after (Indirect).
- Open-market sale: disposed of 290 Common Stock on August 28, 2026; holds 5,692,933 after (Indirect).
- Other acquisition/disposition: acquired 5,436,830 Pre-Funded Warrants at $0.00 ($544) on July 30, 2026; holds 5,436,830 after (Indirect).
- In-the-money derivative exercise: disposed of 5,436,830 Pre-Funded Warrants at $0.00 ($544) on August 28, 2026 (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $0 of stock on the open market.
Insider Transactions
Andrew Regan — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-28 | Other acquisition/disposition | Common Stock | 5,436,830 | — | — | 5,693,223 |
| 2026-08-28 | Open-market sale | Common Stock | 290 | — | — | 5,692,933 |
| 2026-07-30 | Other acquisition/disposition | Pre-Funded Warrants | 5,436,830 | $0 | $544 | 5,436,830 |
| 2026-08-28 | In-the-money derivative exercise | Pre-Funded Warrants | 5,436,830 | $0 | $544 | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-28 | Other acquisition/disposition (5,436,830 shares) |
| 2026-08-28 | Open-market sale (290 shares) |
| 2026-07-30 | Other acquisition/disposition (5,436,830 shares) |
| 2026-08-28 | In-the-money derivative exercise (5,436,830 shares) |
Keywords
insider transaction, Form 4, CDT, CDT Equity Inc., bearish, Andrew Regan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.